Drug Utilization Evaluation of Apixaban in Older Patients with Non-valvular Atrial Fibrillation in Ambulatory Care

이성희, 이은숙, 김은경, Kyung Suk Choi, 정혜리, 박진영, 조구영
2019 Journal of Korean Society of Health-System Pharmacists  
Apixaban is non-inferior to warfarin in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. The clinical use of apixaban in older patients is carefully regulated by the Health Insurance Review and Assessment Service in South Korea, due to a high bleeding risk. This study aimed to evaluate the patterns of apixaban use and medication adherence. A retrospective study was conducted using the electronic medical record (EMR). The study included patients
more » ... included patients who were 65 years and older with non-valvular atrial fibrillation who were prescribed apixaban from
doi:10.32429/jkshp.2019.36.1.004 fatcat:outayseh3jdmfgfzoubwwtxsxi